Inventor · disambiguated record
Chonglan Lin
Also filed as: Lin Chonglan
1 granted patent·6 pending applications·3 citations·filing 2020–2023
25Inventor score
Top patents by PatentIndex Score
7 records- 0186US12054497B2Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Granted Aug 6, 2024·3 cites·20 claims
- 0258US2024158417A1Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2023·Application pending·0 cites
- 0354US2025084078A1Fused ring-substituted six-membered heterocyclic compound, and preparation method therefor and use thereofGENFLEFT THERAPEUTICS SHANGHAI INC·Filed 2023·Application pending·0 cites
- 0453US2025186456A1Pyrimidine-fused cyclic compound and preparation method and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 0549US2024360154A1Aroyl substituted tricyclic compound, preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2021·Application pending·0 cites
- 0649US2024182465A1Fused ring substituted six-membered heterocyclic compound, preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 0745US2023203060A1Fused tricyclic compound, pharmaceutical composition thereof, and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chonglan Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →